According to data from PharmaCube (Yaozhi), based on cumulative sales statistics from three major domestic channels (hospitals, retail pharmacies, and e-commerce), Tasly's proprietary product—Compound Danshen Dripping Pills—has achieved a ten-year cumulative sales total of 39.2 billion yuan, ranking first among Chinese patent medicine brands and becoming the undisputed top-selling Chinese medicine.